These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 30130143)

  • 1. Dynamic associations between opioid use and anhedonia: A longitudinal study in opioid dependence.
    Lubman DI; Garfield JB; Gwini SM; Cheetham A; Cotton SM; Yücel M; Allen NB
    J Psychopharmacol; 2018 Sep; 32(9):957-964. PubMed ID: 30130143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric properties, validity, and reliability of the Temporal Experience of Pleasure Scale state version in an opioid-dependent sample.
    Garfield JB; Cotton SM; Lubman DI
    Drug Alcohol Depend; 2016 Apr; 161():238-46. PubMed ID: 26944468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that anhedonia is a symptom of opioid dependence associated with recent use.
    Garfield JBB; Cotton SM; Allen NB; Cheetham A; Kras M; Yücel M; Lubman DI
    Drug Alcohol Depend; 2017 Aug; 177():29-38. PubMed ID: 28551591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between anhedonia and marijuana use escalation across mid-adolescence.
    Leventhal AM; Cho J; Stone MD; Barrington-Trimis JL; Chou CP; Sussman SY; Riggs NR; Unger JB; Audrain-McGovern J; Strong DR
    Addiction; 2017 Dec; 112(12):2182-2190. PubMed ID: 28623880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males.
    Zijlstra F; Veltman DJ; Booij J; van den Brink W; Franken IH
    Drug Alcohol Depend; 2009 Jan; 99(1-3):183-92. PubMed ID: 18823721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The assessment of post-detoxification anhedonia: influence of clinical and psychosocial variables.
    Pozzi G; Martinotti G; Reina D; Dario T; Frustaci A; Janiri L; Bria P
    Subst Use Misuse; 2008; 43(5):722-32. PubMed ID: 18393086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study.
    Weiss RD; Potter JS; Griffin ML; Provost SE; Fitzmaurice GM; McDermott KA; Srisarajivakul EN; Dodd DR; Dreifuss JA; McHugh RK; Carroll KM
    Drug Alcohol Depend; 2015 May; 150():112-9. PubMed ID: 25818060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of anhedonia and differential reward processing in prefrontal cortex among post-withdrawal patients with prescription opiate dependence.
    Huhn AS; Meyer RE; Harris JD; Ayaz H; Deneke E; Stankoski DM; Bunce SC
    Brain Res Bull; 2016 May; 123():102-9. PubMed ID: 26711857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical opioid analgesic and heroin dependence: how do treatment-seeking clients differ in Australia?
    Nielsen S; Bruno R; Lintzeris N; Fischer J; Carruthers S; Stoové M
    Drug Alcohol Rev; 2011 May; 30(3):291-9. PubMed ID: 21545560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediation effect of beliefs about pleasure and emotional experience between social anhedonia and prediction of pleasant events.
    Hu HX; Chu MY; Yang Y; Wang LL; Zhang RT; Lui SSY; Cheung EFC; Chan RCK
    Psychiatry Res; 2018 Jun; 264():39-45. PubMed ID: 29626830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of the Dimensional Anhedonia Rating Scale (DARS) in a community sample and individuals with major depression.
    Rizvi SJ; Quilty LC; Sproule BA; Cyriac A; Michael Bagby R; Kennedy SH
    Psychiatry Res; 2015 Sep; 229(1-2):109-19. PubMed ID: 26250147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric evaluation of the Temporal Experience of Pleasure Scale (TEPS) in a German sample.
    Simon JJ; Zimmermann J; Cordeiro SA; Marée I; Gard DE; Friederich HC; Weisbrod M; Kaiser S
    Psychiatry Res; 2018 Feb; 260():138-143. PubMed ID: 29195165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients.
    Zaaijer ER; van Dijk L; de Bruin K; Goudriaan AE; Lammers LA; Koeter MW; van den Brink W; Booij J
    Psychopharmacology (Berl); 2015 Jul; 232(14):2597-607. PubMed ID: 25757673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anhedonia in substance use disorders: a systematic review of its nature, course and clinical correlates.
    Garfield JB; Lubman DI; Yücel M
    Aust N Z J Psychiatry; 2014 Jan; 48(1):36-51. PubMed ID: 24270310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid use 12 months following interdisciplinary pain rehabilitation with weaning.
    Huffman KL; Sweis GW; Gase A; Scheman J; Covington EC
    Pain Med; 2013 Dec; 14(12):1908-17. PubMed ID: 23915328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temperament and character inventory dimensions and anhedonia in detoxified substance-dependent subjects.
    Martinotti G; Cloninger CR; Janiri L
    Am J Drug Alcohol Abuse; 2008; 34(2):177-83. PubMed ID: 18293234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifetime history of heroin use is associated with greater drug severity among prescription opioid abusers.
    Meyer AC; Miller ME; Sigmon SC
    Addict Behav; 2015 Mar; 42():189-93. PubMed ID: 25481453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anhedonia and cognitive function in adults with MDD: results from the International Mood Disorders Collaborative Project.
    McIntyre RS; Woldeyohannes HO; Soczynska JK; Maruschak NA; Wium-Andersen IK; Vinberg M; Cha DS; Lee Y; Xiao HX; Gallaugher LA; Dale RM; Alsuwaidan MT; Mansur RB; Muzina DJ; Carvalho AF; Jerrell JM; Kennedy SH
    CNS Spectr; 2016 Oct; 21(5):362-366. PubMed ID: 26714651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey.
    Amin-Esmaeili M; Rahimi-Movaghar A; Sharifi V; Hajebi A; Radgoodarzi R; Mojtabai R; Hefazi M; Motevalian A
    Addiction; 2016 Oct; 111(10):1836-47. PubMed ID: 27177849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mindfulness is Associated With Increased Hedonic Capacity Among Chronic Pain Patients Receiving Extended Opioid Pharmacotherapy.
    Thomas EA; Garland EL
    Clin J Pain; 2017 Feb; 33(2):166-173. PubMed ID: 28060783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.